The session explores novel technologies and public-private partnerships that can end deaths from influenza in our lifetime. Last flu season saw illnesses, medical visits, hospitalizations, and deaths all higher than the previous season, while vaccination rates were down for the third consecutive year. And experts are closely watching the unprecedented H5N1 avian influenza outbreak for its potential to cause the next influenza pandemic in humans. While there has been long-standing collaboration between the public and private sectors on influenza vaccine, antiviral, preventives, and diagnostic innovation, more can be done. We can save more lives through innovation in easy-to-use diagnostics, rapid access to treatments, improvements in vaccine efficacy, and improved public uptake.